Crystal structure of Alzheimer's disease phospholipase D3 provides a molecular basis for understanding its normal and pathological functions
The FEBS Journal · 2024
DOI: 10.1111/febs.17277 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Kenta Ishii und 8 weiteren Autor:innen. Beteiligte Einrichtung: Structural Biology Laboratory, St Vincent's Institute of Medical Research, Fitzroy, Australia. Hauptthemen laut MEDLINE: Alzheimer Disease, Phospholipase D, Catalytic Domain, Models, Molecular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ARC Industry Transformation Training Centre for Cryo-electron Microscopy of Membrane Proteins, National Health and Medical Research Council.
Themen: Demenz
Abstract (Originalsprache)
Human 5′‐3′ exonuclease PLD3, a member of the phospholipase D family of enzymes, has been validated as a therapeutic target for treating Alzheimer's disease. Here, we have determined the crystal structure of the luminal domain of the enzyme at 2.3 Å resolution, revealing a bilobal structure with a catalytic site located between the lobes. We then compared the structure with published crystal structures of other human PLD family members which revealed that a number of catalytic and lipid recognition residues, previously shown to be key for phospholipase activity, are not conserved or, are absent. This led us to test whether the enzyme is actually a phospholipase. We could not measure any phospholipase activity but the enzyme shows robust nuclease activity. Finally, we have mapped key single nucleotide polymorphisms onto the structure which reveals plausible reasons as to why they have an impact on Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Biology Laboratory, St Vincent's Institute of Medical Research, Fitzroy, Australia.
- Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.
- ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.
ORCID-Profile: Michael W Parker
Förderung
- ARC Industry Transformation Training Centre for Cryo-electron Microscopy of Membrane Proteins
- National Health and Medical Research Council
Zitieren
APA
Ishii, K., Hermans, S. J., Georgopoulou, M. E., Nero, T. L., Hancock, N. C., Crespi, G. A. N., Gorman, M. A., Gooi, J. H., & Parker, M. W. (2024). Crystal structure of Alzheimer's disease phospholipase D3 provides a molecular basis for understanding its normal and pathological functions. The FEBS Journal. https://doi.org/10.1111/febs.17277
Vancouver
Ishii K, Hermans SJ, Georgopoulou ME, Nero TL, Hancock NC, Crespi GAN, et al. Crystal structure of Alzheimer's disease phospholipase D3 provides a molecular basis for understanding its normal and pathological functions. The FEBS Journal. 2024. doi:10.1111/febs.17277
BibTeX
@article{Ishii2024,
author = {Ishii, Kenta and Hermans, Stefan J and Georgopoulou, Maria Eleni and Nero, Tracy L and Hancock, Nancy C and Crespi, Gabriela A N and Gorman, Michael A and Gooi, Jonathan H and Parker, Michael W},
title = {Crystal structure of Alzheimer's disease phospholipase D3 provides a molecular basis for understanding its normal and pathological functions},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.17277}
}
EUVIMED